MedTrace Logo

Polymedication Check - a Randomised Controlled Trial

NCT01739816 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2014-04-09

No results posted yet for this study

Summary

Since October 2010, Swiss community pharmacies can offer a 'Polymedication Check' (PMC) to patients on ≥4 prescribed drugs taken over ≥3 months.

Aims:

To evaluate first experiences shortly after implementation, missed pharmaceutical care issues and barriers to implementation on pharmacist's level as well as patient's acceptance through qualitative and descriptive studies To evaluate the impact of PMC in Swiss primary Care and to evaluate economic, clinical and humanistic outcomes in a subsequent randomized controlled trial.

Conditions

  • Polypharmacy

Interventions

BEHAVIORAL

Medication review

Polymedication Check (PMC) is a pharmacist's led medication review focusing medicines management, adherence issues and other drug related problems. The PMC has been implemented in 2010 as a new cognitive service provided by any community pharmacist to patient with polypharmacy (n\>3 drugs) on long term conditions (\> months). This specialised medication review follows a structured predefined protocol and is reimbursed by swiss health insurances. As an outcome, pharmacist may install a compliance support e.g. weekly filled pill organizer.

Sponsors & Collaborators

  • University of Basel

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    collaborator OTHER

  • Polyclinique Médicale Universitaire, PMU, Lausanne

    collaborator UNKNOWN

  • Swiss Pharmacy Association, pharmaSuisse

    collaborator UNKNOWN

  • Kurt Hersberger

    lead OTHER

Principal Investigators

  • Kurt E Hersberger, Prof. · University of Basel

  • Markus Messerli, MSc · University of Basel

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-02-28
Completion
2014-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01739816 on ClinicalTrials.gov